Project Grant F31DA061493
- This $231,552 federal Project Grant award from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) will support research by The Children's Hospital of Philadelphia (CHOP) to understand the neural mechanisms underlying drug-associated context memories, with the goal of identifying potential therapeutic targets to prevent addiction relapse. The key objectives are to 1) test if inhibiting dentate gyrus neurons active during reward-context memory encoding...
- The University of Pennsylvania received a $527,837 Project Grant award from the National Institute on Drug Abuse, part of the Department of Health and Human Services, to study altered midbrain GABAergic circuitry and its role in driving greater cocaine self-administration. Specifically, the researchers will characterize the functional state of midbrain GABAergic circuitry and the disposition of the KCC2 potassium-chloride cotransporter during cocaine self-administration, extinction, and...
- This two-year, $140,108 project grant from the National Institutes of Health's National Institute of Neurological Disorders and Stroke will fund research into the co-regulation of striatal dopamine and acetylcholine in associative reward learning. The grantee, The Trustees of Columbia University in the City of New York, will investigate how these two neuromodulators interact to drive associative reward learning processes. Specifically, the researchers will test the hypothesis that striatal...
- This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $877,500 to the University of California, San Diego (UCSD) to investigate pre-existing differences in GABAergic and glutamatergic transmission within the central amygdala (CEA) of rats and their potential contribution to individual differences in cocaine addiction susceptibility. The study employs a novel method called RATTACA to predict high and...
- This federal Project Grant award from the National Institute of Mental Health (CFDA 93.242 Mental Health Research Grants) provides $460,855 to New York University School of Medicine to investigate the cellular and circuit mechanisms by which acetylcholine (ACh) promotes associative learning in the primary somatosensory cortex. The key objectives are to: 1) use fluorescent ACh sensors and chemogenetic techniques to study the magnitude and time course of ACh release during different phases of an...
- This federal Project Grant award for $613,017.00, provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), supports research to examine the interdependent neural circuit mechanisms underlying the timing of dopamine reward omission signals and striatal dynamics in mice. The project, conducted by the University of California, Los Angeles (UCLA), aims to elucidate how dopamine and striatal timing processes interact to enable...
- This Project Grant award from the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $1,351,034 to the University of Alabama at Birmingham (UAB) to study the role of somatostatin-expressing interneurons in the prelimbic region of the rodent medial prefrontal cortex and their involvement in natural and drug reward seeking behaviors. The award, with a project period from Apr 15, 2025...
- This federal Project Grant award of $811,112 from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), supports research on the network and circuit dynamics underlying dopaminergic control of sudden insight learning. The principal investigator and research team at the University of California, San Francisco (UCSF) will use a combination of large-scale two-photon calcium imaging, high-density electrophysiology, dopamine sensor fiber...
- This federal Project Grant award of $647,833 from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), supports research conducted by Northwestern University to investigate cellular mechanisms underlying excitation/inhibition imbalance in the medial prefrontal cortex as a convergent pathogenic mechanism across genetic mouse models relevant to schizophrenia. The key research objectives are to: 1) determine the reversal potential of the...
- This Project Grant award of $139,998 from the National Institute on Drug Abuse (NIDA) under the federal Drug Use and Addiction Research Programs (CFDA 93.279) supports research to elucidate the cellular and neurochemical mechanisms underlying cocaine-induced suppression of inhibitory G protein-coupled receptor signaling in the prelimbic cortex of the brain. The research aims to investigate how cocaine exposure weakens the regulation of G protein-gated inwardly rectifying potassium (GIRK)...
DYNAMIC CHANGES IN CHLORIDE HOMEOSTASIS COORDINATES MIDBRAIN INHIBITORY NETWORK ACTIVITY DURING REWARD LEARNING - ABSTRACT THE MECHANISMS UNDERLYING HOW REWARDS ARE LEARNED, AND HOW THEY TRANSLATE INTO BEHAVIOR HAVE BEEN A SUBJECT OF INTEREST TO RESEARCHERS AND SCIENTISTS SINCE PAVLOV'S CLASSICAL CONDITIONING EXPERIMENTS IN THE 1890S. RECENTLY, GAMMA AMINO BUTYRIC ACID (GABA) NEURONS IN THE VENTRAL TEGMENTAL AREA (VTA) HAVE EMERGED AS KEY MODULATORS OF REWARD LEARNING, AND POTENTIAL THERAPEUTIC TARGETS FOR ADDRESSING ADDICTION, DEPRESSION, AND OTHER NEUROPSYCHIATRIC DISORDERS. PREVIOUS STUDIES HAVE SHOWN THAT GABA NEURONS IN THE VTA UNDERGO A FORM OF EXPERIENCE-DEPENDENT PLASTICITY THAT INVOLVES THE DOWNREGULATION OF THE ANION TRANSPORTER, KCC2. THIS REDUCTION OF KCC2 LEVELS HAS BEEN FOUND TO INCREASE THE EXCITABILITY OF GABA NEURONS BY DECREASING THE EFFICACY OF GABAA RECEPTOR FUNCTION. IN THE CONTEXT OF DRUGS OF ABUSE AND AVERSIVE STIMULI, THIS MECHANISM HAS BEEN STUDIED IN GREAT DETAIL. FOR INSTANCE, EXPOSURE TO NICOTINE AND STRESS HAS SHOWN TO INDUCE KCC2 DOWNREGULATION IN THE VTA, WHICH IN TURN, ENHANCES THE FORMATION OF REWARD-SEEKING BEHAVIORS. THE IMPACT OF THIS MECHANISM ON SPECIFIC REWARD-RELATED PATHWAYS AND ITS CONTRIBUTION TO NATURALISTIC REWARD LEARNING, HOWEVER, REMAINS UNKNOWN. TO INVESTIGATE THIS MATTER, I PROPOSE TO CHARACTERIZE THE EXPRESSION OF KCC2 THROUGHOUT THE COURSE OF CUE-REWARD ASSOCIATIVE LEARNING, AND DETERMINE WHETHER ITS DOWNREGULATION IS LIMITED TO A SPECIFIC CIRCUIT (AIM 1). MY PRELIMINARY EVIDENCE DEMONSTRATES THAT KCC2 DOWNREGULATION SHIFTS LATERAL VTA GABA NEURONS TOWARDS EXCITABILITY AT CRITICAL TIME POINTS DURING REWARD LEARNING. MORE PRECISELY, KCC2 DOWNREGULATION TRANSIENTLY IMPACTS INHIBITORY INPUTS TO LATERAL PROJECTING VTA DA NEURONS, WHICH ARE KNOWN TO PLAY A SIGNIFICANT ROLE IN REWARD LEARNING. SUBSEQUENTLY, I SEEK TO UNDERSTAND HOW A COLLECTION OF INHIBITORY NEURONS UNDERGOING THIS FORM OF SYNAPTIC PLASTICITY CAN INFLUENCE THE LATERAL VTA AT THE NETWORK LEVEL (AIM 2). TO THIS END, I WILL COMBINE MULTI-UNIT TETRODE RECORDINGS WITH PHARMACOLOGICAL AND GENETIC APPROACHES TO EXAMINE NEURAL NETWORK ACTIVITY DURING REWARD LEARNING. MY PRELIMINARY DATA SHOWS THAT KCC2-MEDIATED PLASTICITY DRIVES INCREASED SYNCHRONIZED ACTIVITY BETWEEN VTA GABA NEURONS. THIS MULTIDISCIPLINARY PROPOSAL WILL INVESTIGATE WHETHER CIRCUIT-SPECIFIC MODIFICATIONS IN KCC2 SERVE AS AN INNATE MECHANISM DURING REWARD LEARNING THAT ALLOWS THE BRAIN TO ESTABLISH ENDURING ASSOCIATIONS BETWEEN CONTEXTUAL CUES AND APPETITIVE STIMULI. THE FINDINGS FROM THIS PROPOSAL WILL GUIDE NEW THERAPEUTIC AVENUES FOR NEUROPSYCHIATRIC DISORDERS WITH DEFICITS IN REWARD LEARNING.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | ($990) | 9/24/25 | ||
| Not listed | ($25k) | 10/9/24 | ||
| Not listed | $0 | 5/7/24 | ||
| Not listed | $0 | 5/7/24 | ||
| Not listed | $1.3k | 4/30/24 |